 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
With IBS Acquisition, Qiagen to Focus on NGS for Clinical Research and MDx; First Target is Cancer
June 27, 2012
With IBS Acquisition, Qiagen to Focus on NGS for Clinical Research and MDx; First Target is Cancer
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Qiagen Plans Mid-Year Launch of Clinical NGS Platform; Says Gene Panels will Complement RT-PCR Tests
January 9, 2013 / Clinical Sequencing News - Azco Sues Qiagen and IBS for Breach of Contract, Fraud over Qiagen's IBS Acquisition
October 29, 2012 / In Sequence - Qiagen Plans to Launch First NGS Products in 2013; Technology will Complement RT-PCR, Pyrosequencing
August 1, 2012 / Clinical Sequencing News - Qiagen Enters NGS Market with IBS Buy; Plans New Platform with Focus on Sequencing Workflow
June 26, 2012 / In Sequence - People in the News: Joachim Schorr, Mark Elander, Nancy Kelley
March 13, 2013 / Clinical Sequencing News